HSPA9 and cancer: In light of the information that overexpression of mortalin and PARP1 [5, 21, 46] promotes cell migration, invasion and angiogenesis, we next asked if inhibition of mortalin and PARP1 by Mortaparib was sufficient to block these phenotypes of cancer cells.